Cargando…
Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980220/ https://www.ncbi.nlm.nih.gov/pubmed/35391899 http://dx.doi.org/10.3389/ti.2022.10357 |
_version_ | 1784681341092102144 |
---|---|
author | Schimpf, Judith Davidovic, Tamara Abbassi-Nik, Armin Sprenger-Mähr, Hannelore Lhotta, Karl Zitt, Emanuel |
author_facet | Schimpf, Judith Davidovic, Tamara Abbassi-Nik, Armin Sprenger-Mähr, Hannelore Lhotta, Karl Zitt, Emanuel |
author_sort | Schimpf, Judith |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8980220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89802202022-04-06 Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients Schimpf, Judith Davidovic, Tamara Abbassi-Nik, Armin Sprenger-Mähr, Hannelore Lhotta, Karl Zitt, Emanuel Transpl Int Health Archive Frontiers Media S.A. 2022-03-22 /pmc/articles/PMC8980220/ /pubmed/35391899 http://dx.doi.org/10.3389/ti.2022.10357 Text en Copyright © 2022 Schimpf, Davidovic, Abbassi-Nik, Sprenger-Mähr, Lhotta and Zitt. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Health Archive Schimpf, Judith Davidovic, Tamara Abbassi-Nik, Armin Sprenger-Mähr, Hannelore Lhotta, Karl Zitt, Emanuel Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients |
title | Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients |
title_full | Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients |
title_fullStr | Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients |
title_full_unstemmed | Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients |
title_short | Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients |
title_sort | enhanced sars-cov-2 antibody response after a third heterologous vector vaccine ad26covs1 dose in mrna vaccine-primed kidney transplant recipients |
topic | Health Archive |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980220/ https://www.ncbi.nlm.nih.gov/pubmed/35391899 http://dx.doi.org/10.3389/ti.2022.10357 |
work_keys_str_mv | AT schimpfjudith enhancedsarscov2antibodyresponseafterathirdheterologousvectorvaccinead26covs1doseinmrnavaccineprimedkidneytransplantrecipients AT davidovictamara enhancedsarscov2antibodyresponseafterathirdheterologousvectorvaccinead26covs1doseinmrnavaccineprimedkidneytransplantrecipients AT abbassinikarmin enhancedsarscov2antibodyresponseafterathirdheterologousvectorvaccinead26covs1doseinmrnavaccineprimedkidneytransplantrecipients AT sprengermahrhannelore enhancedsarscov2antibodyresponseafterathirdheterologousvectorvaccinead26covs1doseinmrnavaccineprimedkidneytransplantrecipients AT lhottakarl enhancedsarscov2antibodyresponseafterathirdheterologousvectorvaccinead26covs1doseinmrnavaccineprimedkidneytransplantrecipients AT zittemanuel enhancedsarscov2antibodyresponseafterathirdheterologousvectorvaccinead26covs1doseinmrnavaccineprimedkidneytransplantrecipients |